Pharma Foods International Co., Ltd. (2929.T)

JPY 897.0

(-1.43%)

Net Income Summary of Pharma Foods International Co., Ltd.

  • Pharma Foods International Co., Ltd.'s latest annual net income in 2024 was 3.2 Billion JPY , up 4.02% from previous year.
  • Pharma Foods International Co., Ltd.'s latest quarterly net income in 2024 Q3 was 1.08 Billion JPY , up 125.73% from previous quarter.
  • Pharma Foods International Co., Ltd. reported an annual net income of 3.08 Billion JPY in 2023, up 923.8% from previous year.
  • Pharma Foods International Co., Ltd. reported an annual net income of -374 Million JPY in 2022, down -109.74% from previous year.
  • Pharma Foods International Co., Ltd. reported a quarterly net income of 1.34 Billion JPY for 2024 Q4, up 23.99% from previous quarter.
  • Pharma Foods International Co., Ltd. reported a quarterly net income of 482 Million JPY for 2024 Q2, up 68.53% from previous quarter.

Annual Net Income Chart of Pharma Foods International Co., Ltd. (2024 - 2008)

Historical Annual Net Income of Pharma Foods International Co., Ltd. (2024 - 2008)

Year Net Income Net Income Growth
2024 3.2 Billion JPY 4.02%
2023 3.08 Billion JPY 923.8%
2022 -374 Million JPY -109.74%
2021 3.84 Billion JPY 456.67%
2020 690 Million JPY 38.04%
2019 499.84 Million JPY 59.36%
2018 313.66 Million JPY 209.61%
2017 101.31 Million JPY 291.22%
2016 25.89 Million JPY 113.78%
2015 -187.88 Million JPY -2227.58%
2014 8.83 Million JPY -96.72%
2013 269.34 Million JPY 348.66%
2012 60.03 Million JPY 228.82%
2011 -46.6 Million JPY -405.67%
2010 15.24 Million JPY 107.34%
2009 -207.57 Million JPY 54.38%
2008 -455.01 Million JPY 0.0%

Peer Net Income Comparison of Pharma Foods International Co., Ltd.

Name Net Income Net Income Difference
Takeda Pharmaceutical Company Limited 144.06 Billion JPY 97.775%
Sumitomo Pharma Co., Ltd. -314.96 Billion JPY 101.018%
Shionogi & Co., Ltd. 162.03 Billion JPY 98.022%
Wakamoto Pharmaceutical Co.,Ltd. 108.95 Million JPY -2841.473%
Nippon Shinyaku Co., Ltd. 25.85 Billion JPY 87.602%
Kaken Pharmaceutical Co., Ltd. 8.02 Billion JPY 60.062%
Eisai Co., Ltd. 42.4 Billion JPY 92.442%
Morishita Jintan Co., Ltd. 697 Million JPY -359.828%
Hisamitsu Pharmaceutical Co., Inc. 13.96 Billion JPY 77.056%
Mochida Pharmaceutical Co., Ltd. 4.54 Billion JPY 29.514%
Fuso Pharmaceutical Industries,Ltd. 1.37 Billion JPY -132.752%
Nippon Chemiphar Co., Ltd. -180 Million JPY 1880.556%
Tsumura & Co. 16.7 Billion JPY 80.816%
Kissei Pharmaceutical Co., Ltd. 11.16 Billion JPY 71.281%
Torii Pharmaceutical Co., Ltd. 4.11 Billion JPY 22.19%
Towa Pharmaceutical Co., Ltd. 16.17 Billion JPY 80.183%
Fuji Pharma Co., Ltd. 3.43 Billion JPY 6.696%
Zeria Pharmaceutical Co., Ltd. 7.73 Billion JPY 58.545%
KYORIN Holdings, Inc. 5.32 Billion JPY 39.778%
Taiko Pharmaceutical Co.,Ltd. -4.89 Billion JPY 165.488%
Daito Pharmaceutical Co.,Ltd. 3.29 Billion JPY 2.731%
SymBio Pharmaceuticals Limited -1.96 Billion JPY 263.286%
MedRx Co., Ltd -932 Million JPY 443.884%
Mizuho Medy Co.,Ltd. 3.77 Billion JPY 15.082%
Solasia Pharma K.K. -1.11 Billion JPY 388.219%
Modalis Therapeutics Corporation -2.39 Billion JPY 233.998%
ASKA Pharmaceutical Holdings Co.,Ltd. 7.54 Billion JPY 57.522%
Sawai Group Holdings Co., Ltd. 13.69 Billion JPY 76.597%
Cyfuse Biomedical K.K. -589.21 Million JPY 643.948%
Toho Holdings Co., Ltd. 20.65 Billion JPY 84.485%
Koa Shoji Holdings Co.,Ltd. 2.94 Billion JPY -8.779%